2021 ISHEN guidelines on animal models of hepatic encephalopathy.

Szczegóły
Abstrakt

Tytuł:: 2021 ISHEN guidelines on animal models of hepatic encephalopathy.
Autorzy:: DeMorrow S; Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas, Austin, TX, USA.; Department of Internal Medicine, Dell Medical School, The University of Texas, Austin, TX, USA.; Research Division, Central Texas Veterans Healthcare System, Temple, TX, USA.
Cudalbu C; CIBM Center for Biomedical Imaging, Lausanne, Switzerland.; Animal Imaging and Technology, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Davies N; Institute for Liver and Digestive Health, University College London, Royal Free Campus, London, UK.
Jayakumar AR; General Medical Research, Neuropathology Section, R&D Service and South Florida VA Foundation for Research and Education Inc, Obstetrics, Gynecology and Reproductive Sciences, University of Miami School of Medicine, Miami, FL, USA.
Rose CF; Hepato-Neuro Laboratory, CRCHUM, Université de Montréal, Montreal, Canada.
Źródło:: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2021 Jul; Vol. 41 (7), pp. 1474-1488. Date of Electronic Publication: 2021 May 11.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
Język:: English
Imprint Name(s):: Publication: Malden, MA : Wiley-Blackwell
Original Publication: Oxford, UK : Blackwell Munksgaard, c2003-
MeSH Terms:: Hepatic Encephalopathy*/etiology
Hyperammonemia*
Liver Diseases*
Animals ; Disease Models, Animal ; Humans
References:: J Hepatol. 2006 Sep;45(3):419-28. (PMID: 16842882)
Liver Int. 2014 Mar;34(3):379-87. (PMID: 23869990)
Sci Rep. 2017 Aug 24;7(1):9347. (PMID: 28839178)
Toxicol Appl Pharmacol. 2012 Nov 1;264(3):387-94. (PMID: 22980195)
J Hepatol. 2014 Dec;61(6):1260-6. (PMID: 25046848)
Liver Transpl. 2000 Jan;6(1):21-31. (PMID: 10648574)
Arch Biochem Biophys. 2013 Aug 15;536(2):171-5. (PMID: 23567839)
Hepatology. 2020 Feb;71(2):611-626. (PMID: 31220352)
Exp Neurol. 2010 Sep;225(1):219-30. (PMID: 20599974)
Hepatology. 2007 Dec;46(6):1883-92. (PMID: 17705298)
J Neurochem. 2009 Apr;109(2):494-501. (PMID: 19200336)
Front Pharmacol. 2020 Apr 16;11:382. (PMID: 32372950)
Hepatology. 2009 Jul;50(1):165-74. (PMID: 19554542)
Gastroenterology. 1992 Jul;103(1):222-8. (PMID: 1612329)
Neuromolecular Med. 2014 Jun;16(2):360-75. (PMID: 24338618)
Life Sci. 2018 Dec 15;215:11-21. (PMID: 30391466)
Biochem Pharmacol. 2019 Dec;170:113662. (PMID: 31606411)
J Hepatol. 2012 Mar;56(3):626-31. (PMID: 22027577)
Nature. 2004 Sep 9;431(7005):188-91. (PMID: 15356631)
Neurochem Int. 2006 May-Jun;48(6-7):434-40. (PMID: 16563565)
Am J Pathol. 2010 Mar;176(3):1400-8. (PMID: 20075201)
PLoS One. 2012;7(3):e32969. (PMID: 22412961)
Hepatology. 2006 Jun;43(6):1257-66. (PMID: 16729306)
Toxicol Appl Pharmacol. 2019 Sep 15;379:114673. (PMID: 31323263)
Toxicol Sci. 2005 May;85(1):720-6. (PMID: 15716488)
Hepatology. 2020 Mar;71(3):874-892. (PMID: 31378982)
J Hepatol. 2014 Mar;60(3):554-60. (PMID: 24512824)
Hepatology. 2009 Jul;50(1):155-64. (PMID: 19437490)
Hepatology. 1997 Mar;25(3):551-6. (PMID: 9049197)
Scand J Gastroenterol. 2004 Oct;39(10):1000-4. (PMID: 15513341)
Am J Physiol Gastrointest Liver Physiol. 2007 Jul;293(1):G75-83. (PMID: 17363468)
Lab Anim. 2015 Apr;49(1 Suppl):21-9. (PMID: 25835735)
J Hepatol. 2002 Apr;36(4):488-93. (PMID: 11943419)
Metab Brain Dis. 2016 Dec;31(6):1249-1258. (PMID: 27272740)
Eur Surg Res. 1979;11(2):89-98. (PMID: 488151)
Liver Int. 2008 Jan;28(1):117-25. (PMID: 17971093)
J Neurochem. 2014 Nov;131(3):333-47. (PMID: 25040426)
Neuroscience. 2017 Apr 7;347:148-155. (PMID: 28193543)
Scand J Gastroenterol. 2002 Sep;37(9):1077-88. (PMID: 12378705)
Am J Physiol. 1999 Aug;277(2):G455-62. (PMID: 10444460)
J Hepatol. 2012 Jan;56(1):109-14. (PMID: 21835138)
J Neurochem. 1994 Jan;62(1):197-204. (PMID: 8263520)
PLoS One. 2010 Dec 10;5(12):e15360. (PMID: 21170329)
Hepatology. 2010 Dec;52(6):2077-85. (PMID: 20890898)
Exp Mol Pathol. 1968 Oct;9(2):279-90. (PMID: 4952077)
J Hepatol. 2010 Jul;53(1):91-7. (PMID: 20451280)
J Neuroinflammation. 2016 Aug 26;13(1):198. (PMID: 27561705)
Metab Brain Dis. 2013 Jun;28(2):175-8. (PMID: 23124921)
Neurochem Int. 2009 Dec;55(7):601-5. (PMID: 19524003)
Hepatology. 1999 Nov;30(5):1198-205. (PMID: 10534341)
Mol Cell Biochem. 2011 Apr;350(1-2):149-54. (PMID: 21203802)
Hepatology. 2008 Oct;48(4):1184-92. (PMID: 18697211)
Stroke. 1986 May-Jun;17(3):472-6. (PMID: 3715945)
Am J Pathol. 2016 Feb;186(2):312-23. (PMID: 26683664)
Neural Regen Res. 2015 Sep;10(9):1457-62. (PMID: 26604907)
Biomaterials. 2004 Apr;25(9):1613-25. (PMID: 14697863)
Am J Physiol Gastrointest Liver Physiol. 2015 Sep 1;309(5):G400-9. (PMID: 26138462)
Sci Rep. 2017 Jan 12;7:40111. (PMID: 28079146)
Front Cell Neurosci. 2017 Jul 05;11:191. (PMID: 28725183)
Liver Int. 2008 Aug;28(7):948-58. (PMID: 18410282)
Neurochem Int. 2010 Jan;56(2):213-5. (PMID: 19931338)
Am J Surg. 2001 Jul;182(1):58-63. (PMID: 11532417)
J Clin Exp Hepatol. 2019 May-Jun;9(3):362-382. (PMID: 31360029)
J Pediatr Gastroenterol Nutr. 2012 Oct;55(4):384-9. (PMID: 22516863)
Am J Gastroenterol. 2020 May;115(5):783-785. (PMID: 31449156)
J Clin Invest. 2015 Jul 1;125(7):2841-50. (PMID: 26098218)
J Neurosci Methods. 2016 May 30;265:56-71. (PMID: 26219658)
Hepatology. 1996 Aug;24(2):412-8. (PMID: 8690413)
Metab Brain Dis. 2010 Mar;25(1):17-21. (PMID: 20217200)
J Neurol Sci. 2007 Jan 15;252(1):67-75. (PMID: 17169376)
Acta Physiol (Oxf). 2019 Jun;226(2):e13270. (PMID: 30830722)
Liver Int. 2014 Mar;34(3):353-61. (PMID: 23910048)
J Pediatr. 2010 Jun;156(6):936-940.e1. (PMID: 20223479)
PLoS One. 2012;7(5):e36322. (PMID: 22586467)
Exp Neurol. 2000 Feb;161(2):704-13. (PMID: 10686089)
Hepatology. 2001 Aug;34(2):249-54. (PMID: 11481608)
Gastroenterology. 2010 Aug;139(2):675-84. (PMID: 20303348)
Gastroenterology. 2017 Nov;153(5):1416-1428.e2. (PMID: 28802564)
PLoS One. 2013 Jul 23;8(7):e69782. (PMID: 23936100)
Ann Hepatol. 2019 Jan - Feb;18(1):101-108. (PMID: 31113577)
Eur Neuropsychopharmacol. 2014 Oct;24(10):1676-86. (PMID: 25174523)
J Hepatol. 2002 Sep;37(3):340-8. (PMID: 12175629)
Liver Int. 2016 Jun;36(6):837-46. (PMID: 26012885)
HPB Surg. 2009;2009:835965. (PMID: 19794827)
J Surg Res. 1974 Dec;17(6):387-96. (PMID: 4155012)
Hum Exp Toxicol. 2017 Jan;36(1):62-81. (PMID: 26987350)
PLoS One. 2017 Jul 10;12(7):e0180638. (PMID: 28700667)
Liver Int. 2009 Jul;29(6):783-8. (PMID: 19638106)
Cell Mol Gastroenterol Hepatol. 2018 Mar 06;6(1):47-63. (PMID: 29928671)
Pharmacol Biochem Behav. 2005 Jul;81(3):683-7. (PMID: 15970315)
Sci Rep. 2020 May 5;10(1):7536. (PMID: 32372057)
J Hepatol. 2006 Jun;44(6):1105-14. (PMID: 16458990)
Crit Care Med. 2006 Jan;34(1):158-64. (PMID: 16374170)
Exp Pathol. 1988;34(4):229-36. (PMID: 2853079)
J Physiol Pharmacol. 2010 Apr;61(2):241-50. (PMID: 20436226)
J Cereb Blood Flow Metab. 2017 Mar;37(3):927-937. (PMID: 27154504)
Metab Brain Dis. 2010 Jun;25(2):241-9. (PMID: 20431929)
Metab Brain Dis. 2013 Jun;28(2):187-92. (PMID: 23111918)
Proteomics. 2004 Dec;4(12):3960-74. (PMID: 15526343)
Behav Brain Res. 2014 Jun 1;266:94-103. (PMID: 24631392)
Acta Neurochir Suppl. 2012;114:387-91. (PMID: 22327729)
Hepatology. 2016 Oct;64(4):1232-48. (PMID: 27339732)
Gene Expr. 2018 Aug 22;18(3):171-185. (PMID: 29895352)
Brain Behav Immun. 2018 May;70:214-232. (PMID: 29518527)
World J Surg. 2006 Nov;30(11):2014-22; discussion 2023-4. (PMID: 16927066)
Dig Dis Sci. 2001 Mar;46(3):489-94. (PMID: 11318520)
Eur Surg Res. 2012;48(3):163-70. (PMID: 22653087)
World J Gastroenterol. 2004 May 1;10(9):1321-4. (PMID: 15112350)
Scand J Gastroenterol. 2010 Aug;45(7-8):935-43. (PMID: 20443756)
Hepatology. 2011 Jun;53(6):1995-2002. (PMID: 21384402)
J Surg Res. 1991 Sep;51(3):267-70. (PMID: 1881140)
Hepatology. 1999 Sep;30(3):636-40. (PMID: 10462368)
Clin Biochem. 2017 Jun;50(9):537-539. (PMID: 28077275)
Sci China Life Sci. 2014 Mar;57(3):327-335. (PMID: 24554471)
J Hepatol. 2016 Nov;65(5):929-937. (PMID: 27318325)
J Neuroinflammation. 2014 Jul 10;11:121. (PMID: 25012628)
Arch Pathol Lab Med. 2012 May;136(5):471-2. (PMID: 22540295)
Gene. 2008 Oct 15;423(1):23-8. (PMID: 18598744)
Hepatol Commun. 2018 Nov 30;3(1):63-73. (PMID: 30619995)
Am J Vet Res. 2017 Nov;78(11):1313-1318. (PMID: 29076370)
Toxicol Rep. 2016 Apr 13;3:870-879. (PMID: 28959615)
Metab Brain Dis. 2001 Jun;16(1-2):95-102. (PMID: 11726093)
Mol Neurobiol. 2019 Jul;56(7):4718-4729. (PMID: 30377987)
Ann Gastroenterol. 2011;24(4):294-306. (PMID: 24713795)
J Exerc Rehabil. 2015 Jun 30;11(3):133-9. (PMID: 26171378)
Hepatology. 1992 Mar;15(3):449-53. (PMID: 1544626)
Stroke. 2002 Oct;33(10):2478-84. (PMID: 12364741)
Behav Brain Res. 1999 Dec;106(1-2):165-73. (PMID: 10595432)
J Hepatol. 2020 Jun;72(6):1140-1150. (PMID: 31954206)
J Huntingtons Dis. 2014;3(2):145-58. (PMID: 25062858)
J Cereb Blood Flow Metab. 2009 May;29(5):944-52. (PMID: 19259110)
Neurochem Res. 1993 Apr;18(4):539-49. (PMID: 8474573)
Hepatology. 1989 Apr;9(4):594-601. (PMID: 2564368)
Neurochem Int. 2013 Mar;62(4):446-57. (PMID: 23376027)
J Hepatol. 2015 Aug;63(2):388-98. (PMID: 25817557)
Liver Int. 2012 Mar;32(3):410-9. (PMID: 22151131)
Hepatology. 1989 Sep;10(3):311-4. (PMID: 2759549)
Toxicology. 1999 Feb 15;132(2-3):155-66. (PMID: 10433379)
Neurobiol Dis. 2011 Feb;41(2):498-507. (PMID: 21087666)
HPB Surg. 2009;2009:306740. (PMID: 19343196)
Lab Invest. 2015 Aug;95(8):903-13. (PMID: 26006017)
Hepatology. 2000 Apr;31(4):872-7. (PMID: 10733542)
Free Radic Biol Med. 2012 Apr 1;52(7):1228-35. (PMID: 22300646)
Steroids. 2015 Sep;101:37-42. (PMID: 26048446)
Behav Processes. 2015 Jul;116:69-74. (PMID: 25957954)
J Hepatol. 2011 Feb;54(2):272-8. (PMID: 21056502)
Clin Biochem. 2014 Nov;47(16-17):233-6. (PMID: 25175939)
Sci Rep. 2021 Jan 26;11(1):2269. (PMID: 33500487)
Hepatology. 2007 Jun;45(6):1517-26. (PMID: 17523148)
J Physiol. 2016 Dec 15;594(24):7341-7360. (PMID: 27558544)
Liver Transpl. 2013 Jul;19(7):751-61. (PMID: 23554142)
Physiol Behav. 2017 May 1;173:87-94. (PMID: 28119160)
Chem Res Toxicol. 2014 Apr 21;27(4):656-62. (PMID: 24552495)
J Hepatol. 2019 Sep;71(3):505-515. (PMID: 31173812)
Eur Surg Res. 2004 May-Jun;36(3):179-84. (PMID: 15178908)
J Surg Res. 2011 Oct;170(2):e233-42. (PMID: 21816413)
PLoS One. 2015 May 27;10(5):e0128076. (PMID: 26018205)
J Pediatr. 2014 Jul;165(1):65-72.e2. (PMID: 24801243)
Brain Res. 1995 Dec 24;705(1-2):345-8. (PMID: 8821768)
Exp Neurol. 2007 Feb;203(2):555-67. (PMID: 17067578)
Gastroenterology. 1989 Mar;96(3):885-91. (PMID: 2914649)
PLoS One. 2012;7(11):e49670. (PMID: 23166746)
Sci Rep. 2017 Dec 20;7(1):17900. (PMID: 29263339)
Front Physiol. 2017 Aug 31;8:636. (PMID: 28912724)
Nat Sci Sleep. 2014 Nov 04;6:129-35. (PMID: 25395874)
Metab Brain Dis. 2016 Dec;31(6):1303-1314. (PMID: 26253240)
Metab Brain Dis. 2010 Mar;25(1):23-9. (PMID: 20198438)
Eur Surg Res. 2011;46(3):118-26. (PMID: 21252557)
Artif Organs. 1977 Aug;1(1):76-83. (PMID: 616275)
Liver Int. 2013 Apr;33(4):544-51. (PMID: 23331547)
Liver Int. 2013 Feb;33(2):294-300. (PMID: 23295057)
Anat Rec (Hoboken). 2019 Jul;302(7):1169-1177. (PMID: 30290401)
Liver Int. 2014 Oct;34(9):1322-9. (PMID: 25354203)
PLoS One. 2017 Apr 26;12(4):e0176518. (PMID: 28445529)
ASAIO Trans. 1990 Jan-Mar;36(1):21-7. (PMID: 2306387)
Liver Transpl. 2020 Jan;26(1):45-56. (PMID: 31509650)
J Neuroinflammation. 2019 Apr 2;16(1):69. (PMID: 30940161)
Cerebellum. 2010 Sep;9(3):384-97. (PMID: 20405262)
Grant Information:: R01 DK082435 United States DK NIDDK NIH HHS; R01 DK112803 United States DK NIDDK NIH HHS
Contributed Indexing:: Keywords: acute liver failure; behaviour; bile duct ligation; chronic liver disease; hepatic encephalopathy; hyperammonemia; liver toxins; neurological deficits; portocaval anastomosis
Entry Date(s):: Date Created: 20210426 Date Completed: 20210625 Latest Revision: 20230106
Update Code:: 20240104
PubMed Central ID:: PMC9812338
DOI:: 10.1111/liv.14911
PMID:: 33900013
: Czasopismo naukowe

Pełny tekst

This working group of the International Society of Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) was commissioned to summarize and update current efforts in the development and characterization of animal models of hepatic encephalopathy (HE). As defined in humans, HE in animal models is based on the underlying degree and severity of liver pathology. Although hyperammonemia remains the key focus in the pathogenesis of HE, other factors associated with HE have been identified, together with recommended animal models, to help explore the pathogenesis and pathophysiological mechanisms of HE. While numerous methods to induce liver failure and disease exist, less have been characterized with neurological and neurobehavioural impairments. Moreover, there still remains a paucity of adequate animal models of Type C HE induced by alcohol, viruses and non-alcoholic fatty liver disease; the most common etiologies of chronic liver disease.
(© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)

Informacja